Polyvalent and monoclonal antibodies identify major immunogenic proteins specific for human herpesvirus 7-infected cells and have weak cross-reactivity with human herpesvirus 6
Hyperimmune rabbit and mouse sera raised to human herpesvirus 7 (HHV-7)-infected cells and an immune human serum identified 20 [35S]methionine-[35S]cysteine- labelled proteins specific for HHV-7-infected cord blood mononuclear cells, ranging in apparent Mr from 136K to 30K. The major proteins had apparent Mr values of 121K, 100K, 87K, 85K, 60K, 51K, 46K, 42K, 40K and 36K. The human serum also identified seven [3H]glucosamine-labelled glycoproteins, with apparent Mr values of 100K, 89K, 82K, 67K, 63K, 53K and 41K. Four monoclonal antibodies (MAbs) specific for HHV- 7-infected cells were derived. Two reacted with a family of five antigenically related polypeptides (87K, 85K, 70K, 61K and 57K in apparent Mr), designated asthep85 complex. Two reacted with 121K and 51K Mr proteins designated as pl21 and p51, respectively. Human sera react with high frequency with the p85 complex and to a lesser extent with pl21; hence these two proteins appear to be immunodominant for both humans and laboratory animals. The hyperimmune mouse serum and some of the MAbs showed some cross-reactivity with HHV-6A(U1102)- and 6B(Z29)-infected cells. The implications of cross-reactivity with respect to the human immune response to HHV-6 and -7 infections and prevalence analyses are discussed.
BernemanZ. N.,
AblashiD. V.,
LiG.,
Eger-FletcherM.,
ReitzM. S.,
HungC. L.,
BrusI.,
KomaroffA. L.,
GalloR. C.1992b; Human herpesvirus 7 is a T-lymphotropic vims and is related to, but significantly different from herpesvirus 6 and cytomegalovirus. Proceedings of the National Academy of Sciences, U.S.A 89:10552–10556
Campadelli-FiumeG.,
GuerriniS.,
XiaomingL.,
Foa-TomasiL.1993; Monoclonal antibodies to glycoprotein B differentiate human herpesviruses-6 into two clusters, variants A and B. Journal of General Virology 74:2257–2262
ClarkD. A.,
FreelandM. L.,
MackieL. K.,
JarrettR. F.,
OnionsD. E.1993; Prevalence of antibody to human herpesvirus7 by age. Journal of Infectious Diseases 168:251–252
ConeR. W.,
HuangM.-L. W.,
AshleyR.,
CoreyL.1993; Human herpesvirus 6 DNA in peripheral blood cells and saliva from immunocompetent individuals. Journal of Clinical Microbiology 31:1262–1267
EllingerK.,
NeipelF.,
Foà-TomasiL.,
Campadelli-FiumeG.,
FleckensteinB.1993; The glycoprotein B homolog of human herpesvirus 6. Journal of General Virology 74:495–500
Foà-TomasiL.,
BoscaroA.,
Di GaetaS.,
Campadelli-FiumeG.1991; Monoclonal antibodies to gp 100 inhibit penetration of human herpesvirus 6 and polycaryocyte formation in susceptible cells. Journal of Virology 65:4124–4129
Foà-TomasiL.,
GuerriniS.,
HuangT.,
Campadelli-FiumeG.1992; Characterization of human herpesvirus-6 (U1102) and (GS) gp112 and identification of the Z29-specified homolog. Virology 191:511–516
FrenkelN.,
SchirmerE. C.,
WyattL. S.,
KatsafanasG.,
RoffmanE.,
DanovichR. M.,
JuneC. H.1990; Isolation of a new human herpesvirus from human CD4 T-cell. Proceedings of the National Academy of Sciences, U.S.A 87:748–752
GompelsU. A.,
CraxtonM. A.,
HonessR. W.1988; Conservation of glycoprotein H (gH) in herpesviruses: nucleotide sequence of the gH gene from herpesvirussaimiri. Journal of General Virology 69:2819–2829
KondoK.,
KondoT.,
OkunoT.,
TakahashiM.,
YamanishiK.1991; Latent human herpesvirus 6 infection of human monocytes/macrophages. Journal of General Virology 72:1401–1408
LiuD. X.,
GompelsU. A.,
Foà-TomasiL.,
Campadelli-FiumeG.1993; Human herpesvirus-6 glycoprotein H and L homologues are components of the gp 100 complex and the gH external domain is the target for neutralising antibodies. Virology 197:12–22
PellettP. E.,
BlackJ. B.,
YamamotoM.1992; Human herpesvirus 6: the virus and the search for its role as a human pathogen. Advances in Virus Research 41:1–52
SalahuddinS. Z.,
AblashiD. V.,
MarkhamP. D.,
JosephsS. F.,
SturzeneggerS.,
KaplanM.,
HalliganG.,
BiberfeldP.,
Wong-StaalF.,
KramarskyB.,
GalloR. C.1986; Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science 234:596–601
WyattL. S.,
RodriguezW. J.,
BalachandranN.,
FrenkelN.1991; Human herpesvirus 7: antigenic properties and prevalence in children and adults. Journal of Virology 65:6260–6265
YamanishiK.,
OkunoT.,
ShirakiK.,
TakahashiM.,
KondoT.,
AsanoY.,
KurataT.1988; Identification of human herpesvirus 6 as a causal agent for exanthemsubitum. Lancet i:1065–1067
YasukawaM.,
YoshihiroY.,
FurukawaM.,
FujitaS.1993; Specificity analysis of human CD4+ T-cell clones directed against human herpesvirus 6 (HHV-6), HHV-7, and human cytomegalovirus. Journal of Virology 67:6259–6264
Polyvalent and monoclonal antibodies identify major immunogenic proteins specific for human herpesvirus 7-infected cells and have weak cross-reactivity with human herpesvirus 6